Ketofon Tablet DT contains Ketorolac 10 mg, a potent nonsteroidal anti-inflammatory drug (NSAID) indicated for the short-term management of moderate to severe pain. Ketorolac exerts its analgesic and anti-inflammatory effects by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, leading to decreased prostaglandin synthesis, which reduces inflammation, pain, and fever. This disintegrating tablet formulation allows for rapid onset of action, making it suitable for patients requiring quick relief from acute pain conditions such as postoperative pain, musculoskeletal injuries, and dental pain. Ketofon Tablet DT should be used at the lowest effective dose for the shortest duration possible, typically not exceeding five days, to minimize the risk of adverse effects. Common side effects may include gastrointestinal discomfort, nausea, dizziness, and headache. Serious adverse reactions, though rare, can involve gastrointestinal bleeding, renal impairment, and hypersensitivity reactions. Ketofon Tablet DT is contraindicated in patients with active peptic ulcer disease, recent gastrointestinal bleeding, severe renal or hepatic impairment, and known hypersensitivity to ketorolac or other NSAIDs. Caution is advised in elderly patients and those with cardiovascular risk factors. It is essential to adhere to prescribed dosages and consult a healthcare professional before use, especially in patients with comorbid conditions or concurrent medication.